Fig. 3From: The impact of specific pulmonary arterial hypertension therapy on cardiac fluorodeoxyglucose distribution in PET/MRI hybrid imaging–follow-up studyKaplan–Meier curves presenting deterioration-free survival in patients with pulmonary arterial hypertension based on SUVRV/SUVLV ratio in 48 months of observation, log-rank test, p = 0.0007. °, complete events; + , censored events; LV Left ventricle, RV Right ventricle, SUV Standardized uptake valueBack to article page